Journal Information
Vol. 61. Issue 6.
Pages 341-347 (June 2025)
Share
Download PDF
More article options
Vol. 61. Issue 6.
Pages 341-347 (June 2025)
Original Article
Prognostic Value of Adding Blood and Lymphatic Vessel Invasion to the 8th Classification of TNM in Lung Cancer in Stages I and II
Visits
1869
Gemma-María Muñoz-Molinaa,
Corresponding author
gmunozmolina@yahoo.es

Corresponding author.
, Sara Fra-Fernándeza, Alberto Cabañero-Sáncheza, Diego Germán Rojas-Tulae, Cristina Cavestany-García-Matresa, Alfonso Muriel-Garcíab, Usue Caballero-Silvaa, Luis Gorospe-Sarasúac, David Saldaña-Garridoa, Amparo Benito-Berlinchesd, Nicolás Moreno-Mataa
a Thoracic Surgery Department, Ramon y Cajal Hospital, Spain
b Statistics Department, Ramon y Cajal Hospital, Spain
c Radiology Department, Ramon y Cajal Hospital, Spain
d Pathology Department, Ramon y Cajal Hospital, Spain
e Nuestra Señora del Prado Hospital, Department of Pneumology, Ramon y Cajal Hospital, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (5)
Table 1. Patient Characteristics.
Tables
Table 2. Tumor Characteristics (N: 629).
Tables
Table 3. Univariable Analysis for Overall and Cancer-Related Survival (CRS) and Recurrence-Free Survival (RFS).
Tables
Table 4. Multivariable Analysis.
Tables
Table 5. Harrell's Index, AIC, BIC AUC and Brier Score.
Tables
Show moreShow less
Additional material (1)
Figures (1)
Abstract
Objectives

Expanding TNM staging system for lung cancer with the addition of new prognostic factors could enhance patient stratification and survival prediction. The goal of this study is to assess if TNM prognosis capacity could be improved by incorporating other pathological characteristics of surgical specimen.

Methods

We retrospectively reviewed lung cancer resections, stages I–II, performed between January 1st 2010 and May 1st 2019. We collected clinical variables and pathological characteristics, including vascular, lymphovascular and perineural invasion, STAS, necrosis and stromal features. Mortality and recurrence-free survival were assessed with univariable and multivariable Cox analysis. We explored how these factors would modify the TNM Harrel's index.

Results

629 tumors were analyzed. Median overall survival was 53.9 months. Median recurrence-free survival was 47.6 months. Specific survival at 3, 5 and 10 years was 90, 83 and 74%. Recurrence-free survival at 3, 5 and 10 years was 76, 70 and 65%.

The multivariable analysis showed that overall survival was significantly related to TNM classification (p<0.0002), vascular infiltration (HR 1.93, CI 1.42–2.64, p<0.0001), lymphovascular invasion (HR 1.88, CI 1.30–2.71, p<0.0015) and necrosis (HR 1.74, CI 1.24–2.45, p<0.0025). Harrell's index for TNM was 0.6139. Adding vascular, lymphovascular invasion and necrosis, it increased up to 0.6531.

The multivariable analysis showed that specific survival was significantly related to TNM classification (p<0.001), vascular infiltration (HR 2.23, CI 1.44–3.46, p<0.001) and lymphovascular invasion (HR 1.85, CI 1.09–3.13, p<0.021). Harrell's index for TNM was 0.6645. Adding vascular and lymphovascular invasion, it increased up to 0.7103. Recurrence-free survival was related to TNM, vascular infiltration (HR 1.48, CI 1.05–2.09, p<0.023) and lymphovascular invasion (HR 2.40, CI 1.64–3.50, p<0.001). Harrell's index for TNM was 0.6264. Adding vascular and lymphovascular invasion, it increased up to 0.6794.

Conclusions

Including vascular and angiolymphatic invasion in the staging system classification could better stratify patients at risk of recurrence and tumor-related death.

Keywords:
Blood vessel invasion
Lymphovascular invasion
Non-small cell lung cancer
Graphical abstract

Article

These are the options to access the full texts of the publication Archivos de Bronconeumología
Member
If you are a member of SEPAR:
  • Go to >>>SEPAR<<< website and sign in.
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Email
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?